Image Image Image Image Image Image Image Image Image Image
Accessibilitat
Aneu a dalt

Amunt

Title Statins4Drusen

· 03/08/2017

Statins4Drusen

Microbiome associated to macular diseases

· 03/08/2017

The Microbiome Project: microbiota associated to Macula Diseases – µMD

bjophthalmol-2017-310268-F2.large

· 28/07/2017

Geographic atrophy phenotype identification by cluster analysis

Fig 01 ooze

· 24/04/2017

Drusen Ooze: A Novel Hypothesis in Geographic Atrophy

m_iovs_57_10.coverfig

· 30/08/2016

A Swine Model of Selective Geographic Atrophy of Outer Retinal Layers Mimicking Atrophic AMD: A Phase I Escalating Dose of Subretinal Sodium Iodate

neovascularització coroidal

· 06/04/2016

Feeder vessel laser photocoagulation for idiopathic, subfoveal polypoidal choroidal vasculopaty not responding to eithelial growth factor therapy or photodynamic therapy

Direct Visualization of a New Choroidal Vessel...

· 06/04/2016

Direct Visualization of a New Choroidal Vessel on Spectral-Domain Optical Coherence Tomography

Foto Proxima A

· 31/03/2016

Proxima A: Estudi epidemiològic per a pacients amb Atròfia Geogràfica secundària a DMAE (GX29633)

FOTO Proxima B

· 31/03/2016

Proxima B: Estudi epidemiològico per a pacients amb Atròfia Geogràfica secundària a DMAE (GX29639)

· 30/03/2016

Individualized Stabilization Criteria-Driven Ranibizumab versus Laser in Branch Retinal Vein Occlusion: Six-Month Results of BRIGHTER.

· 30/03/2016

Correspondence. Wedge-Shaped Subretinal hyporeflectivity in GA.

· 17/02/2016

Individualized Ranibizumab Regimen Driven by Stabilization Criteria for Central Retinal Vein Occlusion: Twelve-Month Results of the CRYSTAL Study.

· 21/10/2015

Scheduled versus Pro Re Nata Dosing in the VIEW Trials.

Harrier

· 28/09/2015

Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration

DMAE (RTH258)

· 21/09/2015

HARRIER: Assaig clínic en pacients amb neovascularització coroïdal secundària a DMAE

Última modificació 18 Octubre, 2017 - 15:06